glp 1 for weight loss pill Popular GLP-1 medications may have health benefits that extend beyond and blood sugar control, a new study finds GLP-1 Drugs for Weight Loss:

Learn about GLP-1 agonists, what they can help treat, and how they work to promote weight loss

Tirzepatide was approved in 2022 as Mounjaro for diabetes, and in 2024 as Zepbound for obesity, with exclusivity running until May 2027

How much strength training and walking it takes to protect muscle, starting at 6,000 steps and a 10 to 15 minute post-meal walk

A massive study of veterans suggests these medications may quiet cravings far beyond food.

It has been hard enough that Im wondering about Ozempic

Exposures Two cohorts were assembled, with the first composed of patients who started and continued on GLP-1 receptor agonists or DPP-4 inhibitors between 1 January 2007 and 31 December 2020 and the second composed of patients who started and continued on GLP-1 receptor agonists or SGLT-2 inhibitors between 1 January 1 2013 and 31 December 2020